Search results
Gilead’s Twice-Yearly Shot Prevents HIV. Where the Stock Is Headed.
Barrons.com· 2 days agoThe company said an independent data monitoring committee had stopped the Phase...groups, will now...
Gilead's twice-a-year HIV PrEP drug delivers stunning results in late-stage study - San Francisco...
The Business Journals· 2 days agoInjected only twice a year, an HIV PrEP drug developed by Gilead Sciences Inc. showed zero...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 1 day agoPfizer and Moderna are grappling with declining sales of their COVID-19 vaccines and drugs. J&J...
...Higher As Big Tech Stocks Retreat; Nvidia Has Bad Day, But Not As Bad As A Trump Stock (Live...
Investor's Business Daily· 2 days agoShares formed a bullish three-weeks-tight pattern with a 3,242.66 entry and remain in the buy zone...
Decades before Juneteenth became a holiday, Fort Worth had rich history of celebrations
Fort Worth Star-Telegram via Yahoo News· 13 hours agoOne of the earliest Fort Worth Juneteenth celebrations took place in 1882 with “music and dancing,...
Preparing for Opportunities in a Shifting Market
TheStreet.com· 1 day agoFor a while now, the market has had a consistent pattern: big-cap technology leadership, narrow breadth, and late-day rallies that take the Nasdaq 100...
Sharon Stone, Charlize Theron, Wilson Cruz Set for THR’s Social Impact Summit
The Hollywood Reporter via Yahoo News· 4 days agoSharon Stone, Charlize Theron, Wilson Cruz and Thomas Sadoski are among the stars who will discuss...
The Action Has Finally Shifted
TheStreet.com· 2 days agoThe recent pattern of action finally shifted on Thursday. The S&P500, Nasdaq 100 (QQQ) , big-cap technology and Nvidia (NVDA) hit new highs early in the ...
Daily Brief: Apple’s China dilemma
Quartz· 2 days agoOpenAI’s ChatGPT, which Apple is putting in its newest iPhone, iPad, and Mac operating systems, is not available in China.
Paying Peter with patent proceeds
Politico· 1 day ago“This should open the door to more competition,” former FDA Commissioner...the U.S. in the fall and winter of 2023. The alert came the same day that Eli Lilly, which makes ...
